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ABSTRACT
In 2016 the United States black population stood at over 43 million with a projected increase
of 41% by 2060, and the “two or more races” category will increase by 197.8% (Vespa et al.,
2020), thus intensifying the need for diagnostic accuracy of skin diseases for these
demographics. The American Academy of Dermatology (https://www.aad.org, 2020) brochures
as well as dermatology textbooks underrepresent skin of color (SOC) cutaneous appearance
(Louie and Wilkes, 2018), and darker skin tone dermatology education is limited. This
underrepresentation leads to misperceptions, misdiagnoses, and poorer outcomes. The
purpose of this evidence-based practice project was evaluation of a technological tool
implementation aimed at increasing Nurse Practitioner (NP) and Physician Assistant (PA)
diagnostic accuracy in SOC dermatology patients in a large Northern Indiana healthcare
system. NP/PA downloaded the VisualDx application (https://mobile.va.gov/app/visualdx) to
their smartphone, acquired the textbook reference Atlas for Skin of Color (Jackson-Richards
and Pandya, 2014), and were supplied with a Fitzpatrick Skin Type (FST) scale for skin tone
reference (https://www.platinumskincare.com/). For any SOC patient where a biopsy was
performed the NP/PA documented within the chart 1) skin type, 2) use of VisualDx, and 3)
recorded their most confident differential first. The information was forwarded to the NP/PA via
the HIPAA approved Doc Halo (https://halohealth.com/) application. A post-intervention survey
determining satisfaction, ease of use, and perceived interventional tools’ level of bias was also
assigned. Statistical analysis was performed via SPSS using Spearman’s Rho, Cronbach’s
Alpha, and Chi-square. The proposed outcome of 90% or greater diagnostic accuracy was not
achieved (42.9%), resulting in an inverse relationship with participant’s overall satisfaction of the
interventional tools. Key words: (diagnos* OR exam* OR assess* OR screen* OR treat*), (educ*
OR teach* OR learn* OR study* OR train* OR instruct*), (nurs* OR “advanc* pract* nurs*”),
(“skin of color” OR “dark* skin” OR “black skin” OR brown skin”).
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CHAPTER 1
INTRODUCTION
Background
The United States (U.S.) Census Bureau statistics on population growth reveal, that in
1990 one in five Americans were a person of color (POC) and that number is projected to
increase to one in three persons by 2060 (Vespa et al., 2020). Owing to native and foreign-born
immigrant reproduction, these rates could change slightly due to the closed U.S. borders
brought on by COVID-19. Considering the projected increase in POC, it is imperative for
dermatology providers to adapt and educate themselves on disease presentation in this
demographic.
Skin of color (SOC) dermatology patients are underrepresented in textbooks (Louie and
Wilkes, 2018) and patient brochures (https://www.aad.org, 2020), and provider training for
patients in this subgroup is limited unless enrolled in specialized educational programs or the
provider seeks knowledge independently (https://www.skinofcolorsociety.org, 2020). Advanced
Practice Clinicians (APCs) such as Nurse Practitioners (NP) and Physician Assistants (PA)
possess the ability to diagnose and treat dermatology patients (Machin, 2017), but due to the
complexity in SOC, misdiagnoses can happen, not unlike their physician counterparts. Although
there is little research concerning accurate diagnosis in dermatology SOC patients, what is
known is patients with darker skin tones use less sun protection, perceive their skin as
photoprotective, and believe their risk of skin cancer is minimal (Agbai et al., 2014). Persons
with Fitzpatrick Skin Type (FST) IV through VI (Figure 1) do not visit the dermatologist as often
as those with FST I through III and have poorer outcomes due to late-stage diagnosis and
treatment (Buster et al., 2012; Dawes et al., 2016; Drenkard et al., 2019; Gelber et al., 2013;
Hogue and Harvey, 2019; Huang et al., 2019; Lee et al., 2017). Skin color scales such as FST
are subjective, making evaluation and diagnosis even more complicated (Ware et al., 2020).
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Dermatologists, although specialty trained, often struggle to accurately diagnose skin disorders
and lesions in individuals with FST IV-VI due to lack of training and available diagnostic tools.
A comprehensive literature search revealed dermatology providers need further
education in SOC, yet only a small amount of literature dedicated to the diagnosis of darker skin
toned patients is available, thus the implementation of Skin of Color Society and textbooks
dedicated to this population (Jackson-Richards and Pandya, 2014; Kelly and Taylor, 2009).
Specific tools are currently unavailable for darker skin tones except for textbooks and online
references, but image and algorithm technological applications are available and have made
advancements in broader skin type analysis (Carter et al., 2012; Vardell and Bou-Crick, 2012).

Figure 1
Fitzpatrick Skin Type Scale

Note: Reprinted from https://www.platinumskincare.com/ on June 18, 2020.
Copyright permission granted February 21, 2021 by Platinum Skincare Support

Advancements in technology have led healthcare providers toward innovative
educational assistance (Burke and Littenberg 2019). VisualDx is a decision support tool (Vardell
and Bou-Crick, 2012) using photographic images and algorithms to assist providers with

Dermatology in Skin of Color

3

differential diagnoses (Figure 2). This mobile application or desktop reference has the ability to
integrate with UpToDate and several other electronic healthcare platforms. Although VisualDx
was originally targeted for the primary care audience, dermatology providers can implement the
tool as well to expedite diagnosis and treatment.

Figure 2
VisualDx Mobile Application

Note: Reprinted from https://mobile.va.gov/app/visualdx, on July 18, 2020.
Copyright permission granted March 16, 2021 by visualdx.com

The purpose of this evidence-based practice (EBP) project was to evaluate the
implementation of a digital application along with a textbook reference and FST visual aid aimed
at increasing APCs diagnostic accuracy in FST IV-VI.
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Data from the Literature Supporting Need for the Project
National Data
The U.S. population is projected to be more ethnically diverse than ever before, and by
2060 one in three Americans (32%) will be a race other than white (Table 1). By 2060, Asians
are expected to more than double, blacks will increase by >41%, and “two or more races” will
increase by almost 200%, making it the largest race group in the country (Vespa et al., 2020).
State Data
Similar to the national data but limited by number of decades projected (2030), the
expected population growth in Indiana revealed the most growth in the group “two or more
races” at 135% (Table 2) and blacks at 26% (Kinghorn, 2008). With projected growth of almost
750,000 persons by 2030, and of those approximately 285,000 will be POC, if state population
growth remains steady, the possibility of 1.2 million POC could reside in Indiana by 2060.
The statistics of population growth in POC support the need for implementing additional
methods for skin-related healthcare diagnosis and treatment.
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Table 1
United States Population Projections by Race

Note. Reprinted from Demographic Turning Points for the United States: Population
Projections for 2020 to 2060, by Vespa, J., Medina, L., & Armstrong, D. M., 2020 retrieved from
https://www.census.gov/content/dam/Census/library/publications/2020/demo/p25-1144
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Table 2
Indiana Population Projections by Race

Note. Reprinted from Indiana Population Projections by Race and Hispanic Origin by
Kinghorn, M., 2008, retrieved July 25, 2020, from http://www.incontext.indiana.edu/2008/septoct/1.asp

Data from the Clinical Agency Supporting Need for the Project
Seven providers in the dermatology department within a large healthcare system in
Northern Indiana agreed that diagnosing skin disorders in persons with FST IV-VI is difficult due
to a lack of medical training and image availability in general medical textbooks (Kamp, J.,
Keultjes, E., Kelley, K., Martin, S., Pantalena, L., & Sculati, K., personal communication, 2020).
In this dermatology practice, FST was only charted to determine burn risk for those patients
undergoing narrow band ultraviolet light type B therapy (NBUVB) for diseases such as psoriasis,
atopic dermatitis, vitiligo, and pruritis, and data tracking for patient population diversity or
congruence of clinical vs histological diagnosis was non-existent. Considering the relative years
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of dermatology experience in the APCs (<1-4 years), tracking congruence may have proven
helpful in determining if previous didactics hit the mark, but would have resulted in lost
anonymity.
Purpose of the Evidence-Based Practice Project
The purpose of this EBP project was to evaluate the implementation of a technological
tool aimed at increasing APCs diagnostic accuracy in SOC dermatology patients. Considering
projected population growth in POC, increased awareness, knowledge, and accuracy of
diagnoses in this group is crucial.
PICOT Question
For APCs in dermatology, did implementing the tool VisualDx and providing the
reference Atlas for Skin of Color (Jackson-Richards and Pandya, 2014) and FST visual aid
(https://www.platinumskincare.com, 2020) result in diagnostic accuracy in patients with FST IVVI as measured by congruence between clinical and histological diagnosis?
Significance of the EBP Project
Patients with FST IV-VI are under-represented in medical school curriculum and
textbooks (Louie and Wilkes, 2018), and many perceive their dermatological care as inferior
(Gorbatenko-Roth et al., 2019). There are also racial limitations of the FST rating scale (Ware et
al., 2020) confounding the classification and, in turn, the appropriate diagnosis and treatment in
POC. These issues contribute to poorer quality and increased cost of care, unsatisfactory
patient outcomes, and racial disparities in several severe diseases such as Melanoma (Buster
et al., 2012; Dawes et al., 2016; Hogue and Harvey, 2019), Scleroderma (Gelber et al., 2013);
Mycosis Fungoides (Huang et al., 2019); Hidradenitis Suppurativa (Lee et al., 2017), and Lupus
(Drenkard et al., 2019).
Given that skin conditions can be manifestations of internal disorders such as
malignancy, anemia, infection, hormone dysfunction, vascular or abdominal/intestinal disorders
to name a few, an accurate diagnosis early in the disease process is imperative. General
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dermatological training in medical school as well as NP and PA programs are lacking SOC
didactics. Finding new and innovative tools to assist in early, accurate diagnosis will inevitably
increase positive patient outcomes. VisualDx is a quick, easy, inexpensive tool to implement in
any practice with the ability to guide providers through possible differential diagnoses.
Healthcare providers must adapt to the ever-changing patient demographic in order to provide
high quality, effective, dermatological care and remain relevant in their profession.
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CHAPTER 2
EBP MODEL AND REVIEW OF LITERATURE
Evidence-based Practice Model
Overview of EBP Model
Evidence-based practice ensures quality, safe, reliable healthcare. The Johns Hopkins
(JH) Evidence-based Practice Model (Vera, 2018) employs systematic clinical decision-making
using instruments to guide the provider through the evidence critique process. Ten appendices
are included for appropriate evidence appraisal. The JH model (Figure 3) is an effective
approach to implementation of practice projects and is designed for providers to ensure
appropriate use of evidence-based practice. The application of the JH model includes the use of
a three-step process: practice question, evidence, and translation (PET). Each step has five to
eight bullet points to guide the provider through the EBP process. Employing any, or all ten, of
these appendices allow for appropriate evidence appraisal and implementation into clinical
practice.
Found in the JH Appendix A, the PET management guide addresses the three-step
process mentioned prior. Defining the problem, identifying stakeholders, recruiting the team,
and determining leadership is required (Vera, 2018). The literature search begins by exploring
best evidence, then appraises and synthesizes the literature resulting in recommendations for
practice. Lastly, the information translates recommendation into an action plan for
implementation and subsequent dissemination for further review. Within the JH Appendix B, the
question development tool and patient/population/problem, intervention, comparison, and
outcome (PICO) concentrates on the relevance of the problem if it was not addressed in the
clinical setting. Investigation of the clinical problem, for example safety, quality, and outcomes,
as well as determination of essential evidence is imperative to EBP project success. Also, in JH
Appendix C, the stakeholder analysis tool guides the Doctor of Nursing Practice (DNP) student

Dermatology in Skin of Color

10

Figure 3
Johns Hopkins Nursing EBP Model

Note: Reprinted from Johns Hopkins nursing evidence-based practice: model and
guidelines. 3rd ed. By Dang, D., and Dearholt, S, 2017, retrieved July 27, 2020 from
https://www.hopkinsmedicine.org/ . Copyright permission granted July 2020 by ©The Johns
Hopkins Hospital/The Johns Hopkins University

to identify key participants such as managers, supervisors, administrators, patients, colleagues,
providers, or even vendors. Assigning responsibility, seeking approval, and informing these
individuals is paramount to a cohesive project implementation. To determine the strength of the
study, JH Appendix D, evidence level and guide, is applied to each piece of supporting
literature. Leveling of evidence from high (one or I) to low (five or V) with quality ratings in each
level of high (A), good (B), and low (C) allow the student to appropriately critique each study.
Assisting the investigator in determining what type of study was conducted is the JH Appendix E
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research evidence appraisal tool. For example, one can find applicable quality ratings of
quantitative, qualitative, mixed methods, meta-analysis, or systematic reviews. Within the JH
Appendix F, the non-research evidence appraisal tool is used for clinical practice guidelines,
position statements, expert opinions, and organizational information such as quality
improvements, as well as financial and program evaluations. The individual evidence summary
tool in JH Appendix G is the investigator’s reference list with full citations and findings including
observable measures, limitations, evidence rating and quality. The evidence synthesis and
recommendation tool in JH Appendix H is the process of synthesizing the evidence,
generalizing its applicability, and proposing recommendations. The action planning tool of JH
Appendix I translates the evidence and identifies strengths and barriers of the project to recruit
the leader and the team, confirm support, and establish critical timelines. The dissemination tool
of JH Appendix J instructs the student to investigate and assess the information and develop a
way to appropriately convey it to key stakeholders in any number of venues such as publication,
online conferences, oral or poster presentations, or in-services.
Strengths and Limitations of EBP Model
Strengths of the JH model arise from the step-by-step processes in each appendix.
Employing these tools assists the investigator with critique of evidence and implementation into
clinical practice, while other models have less tools for dissemination. Appendix D was the most
helpful to this investigator in qualifying relevant evidence and best practice in technological
healthcare tools, racial disparities in healthcare, provider competencies and dermatological
guidelines. By applying all five tenets of EBP; question, evidence, appraisal, integration, and
evaluation (Melnyk and Fineout-Overholt, 2015), the JH model encourages autonomy,
leadership, and engagement. A limitation of the JH model is the lengthy evaluation process
which employs nineteen steps in three sections and ten appendices, while other EBP models
have on average five to ten steps. The lengthy evaluation process could lead to confusion when
evaluating evidence if not applied systematically.

Dermatology in Skin of Color

12

Application of EBP Model to DNP Project
The application of the JH Model to the project was methodical. Following Appendix A,
the investigator defined the practice question by following the six steps; 1) recruited APCs within
the dermatology practice, 2) defined the problem as difficulty in diagnostic accuracy in SOC, 3)
developed the EBP question (PICOT as mentioned above), 4) identified the stakeholders as two
physicians within the practice, 5) accepted responsibility for project leadership and 6) met with
stakeholders to discuss and refine the project. Evidence was collected following the five steps
which included conducting a thorough internal and external search for evidence, appraising the
level and quality of each piece of evidence, summarizing the individual evidence, synthesizing
the overall strength and quality of the evidence, and developing project recommendations for
change to be implemented within the practice. Translation was achieved in three of the eight
steps by determining the relevance of the recommendations, creating an action plan, and
securing the appropriate support for the project.
Strengths and Limitations of EBP Model for DNP Project
The four limitations of this project recognized were; a small, convenient sample size of
four females (three NPs and one PA) in a dermatology practice at two sites in the same health
care system, length of participant practice in dermatology (<1-4 years), adherence to the
protocol (charting of required information, utilizing VisualDx, referencing the textbook and FST
scale, sending information to the project investigator) with potential violations/omissions due to
human error, volume of daily patients or time management issues, and VisualDx has typically
been implemented in primary care thus dermatology nuances may exist. Increased strength and
validity could be accomplished by increased number of participants, equal and increased years
of educational representation of participants, inclusion of male gender, and inclusion of NPs or
PAs in dermatology from a variety of healthcare institutions. Minimal cost, acceptance of
innovative technological applications, and potential ease of use, as well as the participants
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enthusiastic and encouraged demeanor were all strengths attributed to the project. Additionally,
some of the literature reveal positive implementation and diagnoses using the VisualDx
application.
Literature Search
Sources Examined for Relevant Evidence
A thorough literature search for relevant evidence (Table 3) was conducted through The
Cochrane Library (Wiley), MEDLINE (Ovid), CINAHL (EBSCO), Joanna Briggs Institute (JBI),
Nursing and Allied Health, Health Source: Nursing/Academic Edition and Pubmed yielding four
applicable studies. Based on the minimal evidence discovered in these search engines, an
additional systematic search was conducted through citation chasing and hand searching for
supplementary related evidence, generating five and two studies, respectively. Key words and
phrases included (diagnos* OR exam* OR assess* OR screen* OR treat*), ("skin of color" OR
"dark* skin" OR "black skin" OR "brown skin"), (educ* OR teach* OR learn* OR study* OR train*
OR instruct*), and (nurs* OR "advanc* pract* nurs*"). Limiters were English language, human,
peer reviewed and recent in the last 10 years. Inclusion criteria comprised medical education for
dermatology physicians, NPs and PAs, racial disparities in healthcare, and diagnostic tools.
Exclusion criteria consisted of any study involving patient education of skin disease recognition.
Each database was explored for related studies by applying the key words and terms,
several which were taken from the project PICOT (Figure 4). The Cochrane database yielded 14
studies, yet none were applicable (Table 4). JBI produced a combined guideline on ethnic
diversity skin assessment (Slade, 2019), Medline exhibited the most results at 308, but only one
was useful to the project (Vardell and Bou-Crick, 2012), and CINAHL possessed 86 with two
pertinent studies (Louie and Wilkes, 2018; Sommers et al., 2019). Health Source:
Nursing/Academic Edition contained 55, Nursing and Allied Health revealed 20, and Pubmed
held 24, yet none of these databases resulted in any related studies. Citation Chasing combined
with hand searching discovered seven relevant results (Dawes et al., 2016; NP Scope and
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Standards, 2011; Chou et al., 2017; Lee et al., 2017; Loescher et al., 2018), (Bobonich and
Nolen, 2018; Gorbatenko-Roth et al., 2019).

Table 3
Literature Search
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Figure 4
Literature Search PRISMA

Levels of Evidence
According to the JH Model, Level I studies must be experimental studies, randomized
controlled trials (RCT), explanatory mixed method designs or systematic reviews of RCTs with
or without meta-analysis. Level II evidence will encompass quasi-experimental studies,
explanatory mixed methods, and systematic reviews of combinations of RCTs and quasiexperimental studies with or without meta-analysis. Nonexperimental studies, systematic review
of a combination of RCTs, quasi-experimental and nonexperimental studies, nonexperimental
studies with or without meta-analysis, exploratory, convergent, or multiphasic mixed methods
studies, explanatory mixed method designs, or qualitative study meta-synthesis are all
categorized as Level III evidence. Guidelines, expert opinions based on scientific evidence,
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committee consensus, and position statements comprise Level IV. Level V evidence contains
integrative reviews, literature reviews, quality improvement, financial evaluations, case reports,
and expert opinions based on personal experience.

Level I studies are absent in the searches for this project including during citation
chasing and hand searching (Table 5). Much of the evidence relevant to this project fell into
Level III and below validating the necessity for project implementation. Application of technology
in dermatology was addressed by one Level II quasi-experimental study (Chou et al., 2017) and
one Level V was a technological product review (Vardell and Bou-Crick, 2012). Five Level III
studies were discovered which addressed skin tone (Louie and Wilkes, 2018; Sommers et al.,
2019), racial disparities (Dawes et al., 2016), patient’s perceptions (Gorbatenko-Roth et al.,
2019), and providers competencies (Loescher et al., 2018), all applicable to the topic. All four
Level IV pieces of evidence were guidelines or limited reviews by established organizations for
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cutaneous examinations and recommendations (Bobonich and Nolen, 2018; NP Scope and
Standards, 2011; Lee et al., 2017; Slade, 2019).

Table 5

Appraisal of Relevant Evidence
Appraisal of the evidence utilizing JH Appendices D through G allowed for accurate
leveled appraisals of all findings. In Appendix D, quality ratings are disseminated by the level of
evidence. Levels I-III quality ratings are separated to quantitative or qualitative studies. High
quality (A) quantitative studies demonstrate consistent, generalizable results with sufficient
sample size and definitive conclusions. Three of the five Level III studies applicable to this
project were quantitative (Dawes et al., 2016; Louie and Wilkes, 2018; Sommers et al., 2019;)
while two were qualitative (Gorbatenko-Roth et al., 2019; Loescher et al., 2018) and addressed

Dermatology in Skin of Color

18

race, skin tone, provider training, and black patients' perceptions respectively, and all had
quality ratings of high (A).
Studies with reasonably consistent results and sufficient sample size with fairly definitive
conclusions are rated good quality (B), while those studies where there appeared to be little
evidence, small sample size, and inconsistent results to support the study are graded low
quality (C). Qualitative study leveling is somewhat researcher subjective; high (A) and good (B)
quality are equivalent ratings in single studies and meta-syntheses by disseminating six
methods; transparency, diligence, verification, self-reflection and scrutiny, insightful
interpretation, and participant-driven inquiry. Low quality (C) studies contribute little to the
review of findings and may, but most likely do not, possess any of the six methods mentioned
above. This literature search does not contain any low quality (C) studies.
Levels IV and V have separate quality rating criteria. In Level IV evidence, high quality
(A) and good quality (B) are defined as a current (within the last five years) governmental,
private, public, or professional sponsored material. The difference in A and B quality rating is A
must have documentation of a systematic literature search with consistent results and definitive
conclusions, while quality B may have a thorough literature search with reasonably consistent
results and fairly definitive conclusions. One U.S. university sponsored limited literature review
of Hidradenitis Suppurativa research cohort demographics provided statistical evidence of
underrepresentation in the SOC population in both research studies and clinical trials and
provided recommendations for further research, but did not clearly describe the search method
relegating it to a Level IV B rating. Two of the three guidelines included in this project were
current within five years, established by a national task force (Bobonich and Nolen, 2018) and
international research organization (Slade, 2019), and one was within nine years by a national
dermatology nursing organization (NP Scope and Standards, 2011) defining them as quality A,
B, and A, respectively. Although Slade (2019) is current and appropriately sponsored, there was
very little information applicable to the APC. Low quality (C) evidence is material not sponsored
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by an official organization, is poorly defined with a limited search strategy and insufficient
evidence to draw conclusions, this project is void of this group. In Level V evidence of quality
improvement programs and financial evaluations both high (A) and good (B) quality evidence
possesses clear objectives, consistent results, formal evaluation methods, definitive conclusions
and consistent recommendations, but B quality will have reasonably consistent
recommendations with some reference to scientific evidence, while low quality (C) evidence is
unclear, missing objectives, inconsistent results, poorly defined evaluation methods, and no
recommendations can be made. Level V evidence rating of integrative/literature reviews, expert
opinions, case reports, community standards, clinician experience, and consumer preferences
are quite similar; high quality (A) possesses definitive conclusions from scientific rationale by
expert leaders in their field, good quality (B) draws fairly definitive conclusions from logical
opinions by credible experts, and low quality (C) yields questionable evidence and expertise,
and conclusions cannot be drawn. A product review of this project’s interventional tool was
sponsored by a U.S. university and rated Level V, high (A) quality (Vardell and Bou-Crick,
2012).
Level I Evidence
Unfortunately, there was no Level I evidence available for this EBP project. Although
stakeholder support for the project was strong, it is evident that a gap exists in the literature
regarding dermatological training and representation in SOC persons. This discrepancy
solidifies the need for more research in POC and their specialized presentations and
requirements for treatment. When enough EBP projects are completed on the SOC population,
a large-scale systematic review can be conducted giving further validity to the need for change
and implementation tools.
Level II Evidence
Chou et al. (2017). In this prospective quasi-experiment design study, sixty-four
participants including both genders that were either dermatology residents or sixth year medical
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students, some with previous exposure to a visually-based, computerized diagnostic decision
support system (VCDDSS) such as VisualDx, found that diagnostic accuracy increased by
18.75% and user satisfaction was high when applied in the dermatological setting. Additionally,
discernment of the disease accompanied enhanced judgement. Limitations of the study
included lack of Asian pictures and cost. Implementing VisualDx in this EBP project did not yield
increased diagnostic accuracy despite no limitation of cost.
Level III Evidence
Dawes et al. (2016). Racial disparities in melanoma survival exist. An ecological study
of 96,953 patients with a cutaneous melanoma diagnosis between 1992-2009 found although
whites had a higher incidence of melanoma, survival rates were worse in non-white patients. Of
the 96,953 patients, 91,572 were white, 509 were black, 3293 were Hispanic, and 1219 were
Asian American / Native American / Pacific Islander. Melanoma staging tools including Breslow
depth, nodal involvement, ulceration, stage, and histologic subtype were collected as well as the
usual demographics of age, ethnicity, etc. Black patients’ poorer outcomes were related to all
five melanoma demographics but overall can be attributed to late-stage diagnosis. Although
socioeconomic and insurance status not collected presumably plays a role in timely lesion
detection and outcomes, the need for patient education in this population is necessary since
many POC believe darker skin is photo-protective, and some medical providers agree.
Gorbatenko-Roth et al. (2019). Black patient’s perception of their dermatology care in a
SOC clinic was evaluated in this cross-sectional study employing surveys and focus groups.
Nineteen adult black patients; eighteen women and one man, were divided into four focus
groups (two of same-race providers and two of different-race providers). All participants
reported positive experiences regardless of provider race, but believe dermatologists need
further specialized education in SOC patients. Patients who preferred a black dermatologist
believe their shared culture results in increased knowledge of black skin. The authors note that
as of 2008, dermatology residency program chief residents report expert SOC lectures in only
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25.4% of the didactics and program directors as little as 19.5% of the curriculum. Increasing
SOC education in medical programs as well as increasing diversity in the workforce could
enhance clinical outcomes.
Loescher et al. (2018). NP skin cancer training is minimal unless working in the
specialty of dermatology. Graduate programs have little time to dedicate to specialty
concentrations and offer days to one week in dermatology education. In this updated systematic
review of advanced practice nurses’ (APN) skin cancer detection skills and training, the authors
found that there are few educational opportunities for APNs in clinical skin exams and lesion
detection. The authors search found eight literature databases revealing twelve applicable
studies and note one study by Hartnett and O’Keefe (2016) in which the intervention of an
online educational didactic resulted in improved skin lesion recognition as well as a 223%
increase in appropriate documentation and patient education. Overall, this study revealed
suitably educated APNs can identify suspicious lesions.
Louie and Wilkes (2018). Medical education in SOC should be standard in all
programs. Subtle limitations exist such as underrepresentation of this population in medical
textbook imagery. In this cross-sectional study the researchers selected U.S. editions of four
medical textbooks in the curriculum of twenty, top-ranked U.S. medical schools and selected a
total of 4146 images. After excluding images of bone, muscle, internal organs and
depersonalized schematic diagrams, 1522 images were analyzed for race (white, black, POC)
based on observable characteristics such a skin color, hair texture and color, eye color, and
facial features. Utilizing the Massey-Martin ten-point skin color scale, subject images were
matched to the skin tone palette. This study found there was more diversity in race than
skin tone and there were many chapters where POC are nonexistent. Skin of color was
underrepresented at the textbook, chapter, and topic levels, which may lead to medical bias
and in turn racial healthcare disparities. There are textbooks completely devoted to SOC
(Jackson-Richards and Pandya, 2014; Kelly & Taylor, 2009), yet none are in the general
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curriculum.
Sommers et al. (2019). A prospective cross-sectional study involving 446 women was
performed to determine if the FST scale (Figure 1) is valid for cancer risk assessment and
determined decreased correlation with spectrophotometer measurements, raising questions
about the reliability of FST. The FST was developed to determine a person’s burn risk when
exposed to ultraviolet rays in preparation for NBUVB light treatment in certain skin conditions.
Since then, several skin type scales have been developed, but the FST remains the one most
referenced. This six-point scale from Type I (fair) to Type VI (black) appears insensitive to the
variety of racial and ethnic groups that make up the world’s population, and interestingly use the
term fair instead of white or tan further confusing the user and possibly leading to health
disparities. Although this study raises questions of the validity of the FST, because it is the most
widely used skin type scale and its familiarity with providers, this project used it as a reference
for patients presenting to clinic with skin conditions. No bias was revealed by participants in the
post project survey.
Level IV Evidence
Bobonich and Nolen (2018). This guideline from a NP task force comprised of fourteen
NPs with a minimum of five years’ experience each in dermatology, along with a validation
panel of leadership NPs, specialty education NPs, NP organizations, and credentialing and
certification organizations, achieved a consensus for entry-level competencies, followed by
validation from an external panel. The guideline provides clarity of the role and quality indicators
for practice of dermatology NPs. Of the four detailed competency categories; assessment,
diagnosis, plan and outcomes, and implementation and evaluation, none of the thirty-six bullets
address SOC. With the U.S. skin of color population growing, addressing this sub-specialty has
the potential to increase positive patient outcomes.
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NP Scope and Standards (2011). The Dermatology Nurses Association (DNA) NP
Scope and Standards guideline does not include verbiage surrounding SOC, and this deficit is
concerning. Assessment, diagnosis, and treatment is discussed, as well as scope of practice
and ethics, yet no guidance is available for the POC population. The other guidelines presented
in this paper (Slade, 2019; Bobonich and Nolen, 2018) address SOC patients specifically,
however, the DNA lacks this information. This again highlights the need for more projects in this
patient population.
Lee et al. (2017). Despite a higher incidence of Hidradenitis Suppurativa (HS) in SOC,
research studies within the U.S. and abroad revealed SOC is underrepresented in both cohorts
and clinical trials. Increased disease burden in this population at the quality of life and
depression, genetic, anatomical, metabolic syndrome (MS), access to care, socioeconomic
status, and treatment response exists. Recommendations for future research on all seven of
these topics was presented as well as in increased surveillance of MS, encouraging lifestyle
modifications, evaluating barriers, increased social support, initiating early screening, providing
longitudinal care plans, and increasing HS knowledge in non-dermatologists.
Slade (2019). A guideline found in the Joanna Briggs Institute specifically
addresses ethnic diversity. Recommended best practice and evidence summaries describe skin
exam preparation including asking the patient, family, or caregiver to identify an area of normal
colored skin and use natural or halogen lighting instead of fluorescent light which can create a
bluish tint to the skin. Assessment should be made based on skin tone and not race or ethnicity.
Exam can include palpation since rashes and lesions may not be obvious during visual
inspection. Dermatology providers should be practicing all these recommendations for optimal
skin care regimens, but these alone are not enough.
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Level V Evidence
Vardell and Bou-Crick (2012). A graduate student (Vardell) and her advisor (Bou-Crick)
provide an overview of VisualDx including a description and features. As a diagnostic decision
support tool, VisualDx aids in differential diagnosis for quick point of care treatment plans by
allowing the user to access more than 1,212 unique diagnoses and 24,115 unique images
aimed at providing numerous differential diagnoses. Written by each subjects’ experts after peer
review of over 90,000 images and updated quarterly, this application also provides links to
relevant PubMed articles. It has the ability to integrate with many electronic health platforms, is
available in desktop and mobile versions, and has been updated with the ability to upload a
photo of the patient’s lesion or rash. Entering data such as clinical features, age, distribution,
and time present, the user is guided to several possible diagnoses.
As evidenced by the literature results (Table 6) and absence of Level I studies, further
research is needed in the SOC population and its relationship to dermatology. Of the eleven
studies presented here, two addressed technology and its applicability to dermatological exams,
but no specific mention of its ability to increase diagnostic accuracy in the SOC demographic.
VisualDx was not advantageous in diagnosing FST IV-VI patients during this project.
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Construction of Evidence-based Practice
Synthesis of Critically Appraised Literature
An apparent gap exists in SOC medical education (Adelekun et al., 2020; Louie and
Wilkes, 2018). People of color are underrepresented in American Academy of Dermatology
(AAD) (https://www.aad.org, 2020) brochures and medical textbook images (Louie and Wilkes,
2018), and racial disparities in disease outcomes exist (Buster et al., 2012; Dawes et al., 2016;
Drenkard et al., 2019; Gelber et al., 2013; Hogue and Harvey, 2019; Huang et al., 2019; Lee et
al., 2017). Agbai et al. (2014) estimate black skin has an intrinsic sun protection factor (SPF) of
13.4, whereas white skin SPF is 3.3, prompting persons with darker skin tones to mistake their
color as skin cancer protective and are less likely to follow up with dermatologists frequently.
Gorbatenko-Roth et al. (2019) discussed black patient’s perceptions of their dermatology care
and noted although patients were satisfied, they acknowledged a need for additional education
in darker skin tone care.
Of the three guidelines for NPs included in this paper, only one addresses ethnicity and
SOC (Slade, 2019). The DNA (NP Scope and Standards, 2011) and the NP Task Force
(Bobonich and Nolen, 2018) address competencies as well as scope and standards of practice,
with no mention of race, ethnicity, or skin tone. Considering the SOC population growth at the
national (Vespa et al., 2020) and state levels (Kinghorn, 2008), dermatology providers will
require additional tools to effectively diagnose and treat this patient population.
Loescher (2018) notes that few skin exam and lesion recognition educational
opportunities exist for APNs. This coupled with limited guidelines (Bobonich and Nolen, 2018;
NP Scope and Standards, 2011), subjective skin tone scales (Ware et al., 2020) and lack of
available educational imagery (Adelekun et al., 2020; Louie and Wilkes, 2018), establishes the
demand for instruments to meet the expanding SOC population.
Available medical technology is rapidly expanding. VisualDx (Carter et al., 2012, Vardell
and Bou-Crick, 2012) is an available technological tool with the potential to increase diagnostic
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accuracy. Although Burke and Littenberg, (2019) found VisualDX made no difference in patient
outcomes in their cluster-randomized controlled pragmatic trial, it was only implemented in
primary care practices and could be an additional tool to a dermatology provider with improved
descriptive skills. Vardell and Bou-Crick (2012) note VisualDx is not only compatible with
UpToDate, it can also interface with electronic health care records (EHR) such as EPIC and
Cerner. Successful implementation of VisualDx in this project occurred but was unable to
interface with the Cerner platform utilized by this health system.
Best Practice Model Recommendation
Best practice recommendations comprise enhanced dermatological competencies
(Bobonich and Nolen, 2018) in SOC (Slade, 2019) and application of analytical tools (Chou et
al., 2017) to increase diagnostic accuracy. This can be achieved by implementation of the
VisualDx mobile application (Carter et al., 2012; Vardell and Bou-Crick, 2012). Of course, for
safe and competent care a textbook reference was available to the providers (Jackson-Richards
and Pandya, 2014), and providers must also be cognizant of FST limitations (Sommers et al.,
2019; Ware et al., 2020) for diagnosis and treatment in POC.
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CHAPTER 3
IMPLEMENTATION OF PRACTICE CHANGE
The purpose of this EBP project was to determine whether implementing the mobile
application tool VisualDx (https://www.visualdx.com/) while providing a textbook reference
(Jackson-Richards and Pandya, 2014) and Fitzpatrick Skin Type (FST) visual aid
(https://www.platinumskincare.com/) would result in diagnostic accuracy in patients with FST IVVI as measured by congruence between clinical and histological diagnosis. The population
growth of SOC persons demands providers increase their knowledge in all aspects of
healthcare, including dermatology. VisualDx is a technological application designed to assist in
disease differential building, and ease of use via the mobile application makes it an ideal EBP
project instrument.
Participants and Setting
The setting for this project was a dermatology department in a large healthcare
institution in Northern Indiana employing seven providers at two locations. Participants include
four dermatology APCs and two physicians within the same group. Each APC was assigned a
provider number one through four to retain anonymity. All APCs in this group were women
aged 30-52 years, consist of three NPs and one PA, and have less than one and no more than
four years’ experience as dermatology APCs. Another NP within the department with greater
than ten years’ experience as a dermatology NP served as the project investigator. Of the two
physicians serving as facilitators, one has served as the medical director and Mohs surgeon for
six years and the other has practiced general medical dermatology for greater than one year
post a three-year dermatology residency.
Pre-Intervention Group Characteristics
Based on 2010-2014 data (Figure 5), population characteristics of this Northwest Indiana
city revealed SOC residents comprise approximately 40%, and black’s individual residency
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(27.11%) is more than twice the entire U.S. (12.6%) and three times more than the entire state
of Indiana State (9.15%). With a study group of four APCs and combined SOC population of
41.66%, the dichotomous endpoint of projected 90% accuracy, Alpha of 0.05, Beta 0.2, and
80% power, each provider must submit data on a minimum of six patients.

Figure 5
Population by Race; South Bend, IN

Note: Reprinted from South Bend, IN Population and Races. Retrieved August 23, 2020,
from http://www.usa.com/south-bend-in-population-and-races.htm

Valparaiso University and the provider’s health system internal review boards (IRB) granted
approval. Project implementation began September 8, 2020 and data collection closed February
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10, 2021 when all providers submitted patient information on a minimum of six (Figure 6) with
maximum of ten patients for increased statistical power.

Figure 6
Sample Size Calculator

Note: Reprinted from ClinCalc.com. Retrieved August 23, 2020 from
https://clincalc.com/Stats/SampleSize.aspx. Copyright permission granted February 21, 2021
form Clincalc.com
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Intervention

After Valparaiso and the healthcare system IRB approval, four APCs in the dermatology
department were given the FST visual aid, ordered the textbook reference, and downloaded the
VisualDx mobile application to their personal phones. The participants agreed to use their
continuing education monies to purchase the textbook and the mobile application was free
through their healthcare institution. Personal phones are already utilized by the APCs for at
least twelve other applications necessary for workflow such as AAD, Camera Capture, Doc
Halo, Duo, Epocrates, GoodRx, Jabber, Mohs AUC, UpToDate, Veeva Engage, Webex, Meet,
and Workplace. In any patient with FST IV-VI and performing a biopsy, the APC documented in
the chart 1) skin type, 2) use of VisualDx, and 3) placed their most confident differential first in
the rule out section of the chart. Due to its ease of use and timely communication, the APC sent
those patient’s initials, date of birth (DOB) and date of service (DOS) to the investigator via the
HIPAA approved Doc Halo application (Figure 7) daily or weekly to avoid loss of data. All
information sent to the investigator was documented on a data collection worksheet (Table 7) on
the investigator’s secure work laptop and congruence between clinical and histological
diagnosis was recorded. A participant post-intervention survey was given (Table 8) to determine
if any or all three of the interventions were helpful and if the provider found the FST scale biased
(as discovered in some of the literature discussed here).

Dermatology in Skin of Color

33

Figure 7
Doc Halo mobile application

Note: Reprinted from https://halohealth.com/ on July 22, 2020. Copyright permission
granted March, 2021 by ©HaloHealth. Copyright permission granted from March 15, 2021 from
halohealth.com
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Table 7
Date Collection Worksheet

Comparison
Currently, no previous data collection exists on diagnostic congruence with any skin type
within this practice, and the health system’s IRB chairman viewed this as a quality improvement
project. Implementation of tools facilitating diagnostic accuracy with all skin types could
ultimately lead to patient satisfaction, positive patient outcomes, provider confidence and
possibly cost savings.
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Table 8
Participant Survey

Outcomes
The primary outcome evaluated was diagnostic accuracy as measured by
congruence between clinical versus histological diagnosis. The secondary outcome was
dissected during the post project participant survey to determine if the tools were beneficial in
determining skin type and differential diagnosis.
Time
The project began September 8, 2020 and ended February 10, 2021 when all four APCs
forwarded a minimum of six and maximum of ten patient’s information to the investigator as
determined by power analysis. Reminder emails and text messages were sent to the APCs one
week prior to implementation with directions and start date. The APCs were notified when data
collection was complete.
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Protection of Human Subjects

This investigator completed the NIDA six-hour clinical course on protection of human
subjects (Figure 8). The data collection worksheet was kept in a file on the investigator’s secure
workplace laptop. The DOS, patient initials, and DOB information given to the investigator by
the APCs was used to locate the patient’s chart and only patient initials and DOS was
documented on the flowsheet for patient identity protection. Each APC was assigned a number
that only the investigator knew for documentation on the data collection sheet for participant
identity protection. Informed consent (Figure 10) was obtained from the APCs and all questions
were answered.

Figure 8
Protection of Human Subjects Certificate
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Informed Consent
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CHAPTER 4
FINDINGS

Implementation of the VisualDx application in SOC patients revealed weak correlation
with use of the application and congruence between clinical and histological diagnoses, as
congruence was noted in less than half of the biopsies performed. A post-project survey
revealed provider satisfaction with all three tools: VisualDx, Atlas for Skin of Color (JacksonRichards and Pandya, 2014), and FST Scale. Statistical analysis was completed using SPSS 25
and the following statistical tests were utilized for such analysis: Chi Square, Spearman’s Rho,
and Cronbach’s Alpha.
Participants
All four APC participants in the dermatology department utilized the VisualDx application
to populate diagnostic differentials for any FST IV-VI patient requiring a biopsy for diagnosis
confirmation. A total of 28 shave or punch biopsies were performed during September 8, 2020
to February 10, 2021. The shave or punch biopsies were documented (Table 9) and all were
included in statistical analysis. A slight majority were FST V (n = 14), compared to VI (n = 12)
and IV (n = 2) (Figure 10). There was no comparison group for this EBP project nor attrition. A
post project survey in Likert Scale format (Table 8) evaluating satisfaction of the implemented
tools was given and all participants returned the forms promptly to the investigator.
Changes in Outcomes
Data suggests that VisualDx had little direct impact with assisting in accurate
pathological diagnosis in the SOC population (Figure 11). Several extraneous variables could
have impacted this such as relative years of the APCs dermatology experience, a new
technological application, and more directly, patient skin type.
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Table 9
Clinical and Histological Diagnoses

Statistical Testing and Significance
Statistical and clinical significance was determined via SPSS 25 analysis and interpreted
calculations. Congruence was found in only 42.9% (n = 12) of the patients versus 57.1% (n =
16) that were not (Table 10). Frequency distribution of congruence was split according to the
provider, each with at least one (16.7%) and no more than 5 (83.3%) congruent diagnoses
(Table 11). Two providers had more than six patients which could have allowed for a slight
percentage manipulation yet revealed no significant association between provider and
congruence with a p > 0.05 (.110) (Table 12). The association between provider, skin type and
congruence can be visualized in Figure 12.
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Figure 10
Fitzpatrick Skin Type Distribution

Figure 11
Congruence Distribution
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Congruence Frequency

Table 11
Provider Congruence
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Table 12
Provider/Congruence Association

Figure 12
Skin Type by Provider by Congruence
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There was no significance found insinuating that continuous use of VisualDx lead to
increased congruence (one APC improved with one congruence only at project end). A Chi
square analysis was conducted to investigate whether a difference existed between congruence
and skin type (Table 13). Assumptions were checked and results indicate congruence
significantly differs among skin types; x2 (2) = 7.19 and p = .027. Strength of the association
between the two variables was indicated by a Phi of .507 (Table 14).

Table 13
Congruence/Skin Type Difference

Table 14
Association Strength
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Not surprisingly, FST VI had the least congruence 62.5% (n = 10) and the only two
cases of FST IV were congruent, which aligns with the information in chapters one and two
about the challenges of diagnosing darker skin tones (Table 15 and Figure 13).

Table 15
Congruence by Skin Type

Figure 13
Skin Type and Congruence
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Findings
Although VisualDx is an accessible, easily navigated mobile and desktop application, it
does not appear to have assisted in accurate diagnosis in SOC patients. As the investigator
suspected, nearly all the differentials and histological diagnoses (some duplicates) were related
to inflammatory eruptions and not skin cancer (Table 9); this phenomenon is discussed in
further detail in chapter 5. An argument could be made that it may be accurate in patients with
lighter skin tones (FST I-III), but this project was focused on darker skin tone patients which has
been shown in the literature to be more diagnostically complex.
Primary Outcome
Clinical and Histological Congruence. Congruence was found in only 12 (42.9%) of
28 biopsies revealing little assistance from the VisualDx application (Figure 11).
Satisfaction of Tools. Post project surveys revealed satisfaction with all three
implemented tools. Ease of use was verbalized by all four APCs as a major factor in successful
implementation. All four providers stated ease of use of the VisualDx application, three out of
four stated VisualDx images were helpful (one stated somewhat helpful), and only one felt the
SOC subgrouping was very helpful while the other three felt it was somewhat helpful or were
indifferent. All four APCs felt the FST scale images were very helpful, ease of use was helpful
for three APCs while one felt it was somewhat helpful, and three felt it was unbiased, and one
was indifferent regarding bias content. The Atlas for Skin of Color (Jackson-Richards and
Pandya, 2014) textbook reference was also evaluated for ease of use (two very helpful, one
somewhat helpful, and one indifferent), images (two very helpful and two somewhat helpful),
and differential diagnosis (two very helpful and two indifferent). All four APCs were appreciative
of the tools provided.
Validity of tools. Cronbach’s Alpha was performed on the post project surveys and data
collection worksheet. A Cronbach’s Alpha approaching 0.7 for reliability and validity revealed
internal consistency of survey questions (Table 16). This rang true when discussions post
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project between the investigator and the participants confirmed their opinions of the
implemented tools with survey answers.

Table 16
Cronbach’s Alpha Internal Consistency

Spearman’s Rho for correlations was conducted for each survey item and revealed an
unremarkable negative correlation coefficient with df = 2 and p > .05 including the survey
question about FST scale bias. Although the surveys state the implemented tools were helpful,
the results of the congruence analysis would indicate otherwise.
Secondary Outcome
VisualDx will continue to be utilized by the dermatology APCs for differential
building in complicated cases of all skin types. The desktop and mobile applications are
available at no cost to all current employees within the health system and they are encouraged
to use it as a trusted resource.
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CHAPTER 5
DISCUSSION

Dermatology SOC patients have a higher incidence of misdiagnosis, late-stage
diagnosis, and poorer outcomes than lighter skin-toned persons (Buster et al., 2012; Dawes et
al., 2016; Drenkard et al., 2019; Gelber et al., 2013; Hogue and Harvey, 2019; Huang et al.,
2019; Lee et al., 2018). With the United States black and “two or more races” population
projection increases of 41% and nearly 200% by 2060 (Vespa et al., 2020), the need for
diagnostic accuracy regarding these demographics is imperative. The answer to the PICOT
question for this EBP project “For APCs in dermatology, does implementing the tool VisualDx,
while providing the reference Atlas for Skin of Color (Jackson-Richards and Pandya, 2014) and
FST visual aid result in diagnostic accuracy in patients with FST IV-VI as measured by
congruence between clinical and histological diagnosis?”, was no. This chapter will explore the
results as well as the contributory strengths and weaknesses of the project and its implications
and recommendations for the future.
Explanation of Findings
VisualDx, although helpful and easily navigated by the APCs, did not increase diagnostic
accuracy in this small participant group. The proposed outcome of 90% or greater diagnostic
accuracy was not achieved (42.9%), resulting in an inverse relationship with participants overall
satisfaction of the interventional tools. Of the 28 patients, most were FST V (n = 14), compared
to VI (n = 12) and IV (n = 2). Although there was no comparison group, neither was there
attrition. A post project survey noted all participants were satisfied with the implemented tools.
Only two providers saw one FST IV patient each and both were congruent, FST VI
revealed 10 (62.5%) non-congruent patients and most patients were FST V with a split
congruence of seven each. Frequency distribution of congruence ultimately ranged from 16.7%
to 83.3% despite two providers performing more than six biopsies each. Although SOC is known
to be diagnostically challenging, previous training may have created a discord between
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differentials and learned materials as well as descriptors. Nearly all the differentials and
histological diagnoses (some duplicates) were related to inflammatory eruptions and not skin
cancer. These findings align with the challenges of diagnosing darker skin tones and the
literature search results revealing racial disparities exist among these disease processes: Lupus
(Drenkard et al., 2019), Scleroderma (Gelber et al., 2013), Mycosis Fungoides (Huang et al.,
2019), and Hidradenitis Suppurativa (Lee et al., 2018).
Carter, Farrell, and Mason, (2012) note that technology in medicine is expanding and
reviewed both the desktop version and mobile application VisualDx which was developed in
2006 as a diagnostic decision support tool for the skin, external eye, and oral mucosa. They
found it contains >22,000 images of >1200 conditions and increases with peer-reviewed
quarterly updates. This technology is unique in its ability to construct differential diagnoses from
nine different scenarios and is four times more likely to produce an accurate diagnosis than
without. The seven modules; eye, oral, pediatric skin, adult skin, pulmonary, public health, and
drug reactions, implemented with lesion type, location, distribution, and key findings supplies the
differential diagnoses. Data used is collected from institutions, physicians, and documented
collections. It has the ability to interface with UpToDate and other EHR such as EPIC and
Cerner, and is available for iPhone, iPad, iPod, and Android devices. Annual subscription cost
varies from $29.99 (limited access) to $99, less for students, fellows, and residents, and free to
some providers through their institution (if purchased as an organizational package). Internet
connection is required for use.
Not unlike this EBP project, Burke and Littenberg, (2019) discovered VisualDX had no
impact on patient outcomes in their cluster-randomized controlled pragmatic trial, but could have
been limited by its cohort of primary care practices only. A comparison project including
dermatology, primary care, urgent care, and rheumatology would likely yield interesting results.
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Strengths and Limitations of the DNP Project
Strengths
VisualDx added a separate SOC category 10/14/2020, approximately one month into the
project. The post project survey revealed one provider felt it was very helpful, two agreed it was
somewhat helpful, and one was indifferent to the subcategory. Minimal cost, acceptance of
innovative technological applications, and potential ease of use, as well as the participants
enthusiastic and encouraged demeanor were all strengths attributed to the project. Additionally,
some of the literature revealed positive implementation and diagnosis using the VisualDx
application.
This practice, like most dermatology offices, send their biopsy tissue specimens to a
dermatopathology lab where dermatologists and pathologists are double-boarded and specialty
trained in cutaneous lesions, rashes, autoimmune diseases, etc., assisting in diagnosing
complicated skin disease. This investigator did not track which lab evaluated each specimen,
but both are dermatopathology laboratories and stated provider confidence exists. There was no
attrition.
Limitations
Selection bias existed as all four APCs worked in the same health system department
and all were female. Relative years of experience varied from less than one to four, possibly
skewing the results due to inexperience. For optimal patient care it is acceptable to
acknowledge the APCs may have collaborated with colleagues or used other references (UTD
or additional textbooks) to arrive at a diagnosis. The APCs may not have chosen the VisualDx
differential as their first choice, and tracking all differentials was not performed. There was no
comparison group allowing for increased validity to implementation of any tool, nor was there
data tracking of previous or concurrent education which may have been helpful in determining if
previous didactics were beneficial.
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Protocols may have deviated due to daily patient flow or volume, time management,
human error, or technological issues. None of these were reported to the investigator. Although
VisualDx is applicable to any provider attempting to diagnose and understand a cutaneous
condition, it is aimed at primary care, therefore, dermatology nuances may exist. Increased
strength and validity could be accomplished by increased number of participants, equal and
increased years of educational representation of participants, inclusion of male gender, and
inclusion of NPs or PAs in dermatology from a variety of healthcare institutions. Any deviation
from the project protocol, although in the best interest of the patient, may have led to unknown
errors, introducing additional bias.
Due to the Covid-19 pandemic, VisualDx allowed its users to utilize the “take a photo”
option free of charge from April - December of 2020 (typically $99/year) to assist with timely
cutaneous diagnosis. None of the providers purchased the photo option, instead choosing to
build their differential with demographic and descriptive characteristics as outlined in the
application.
Implications for the Future
Practice
Dermatology providers have specialized training in skin disorders and lesions, with
ongoing didactics contributing to their knowledge base. Although VisualDx was created for
primary care and urgent care providers, this application can be useful to anyone attempting to
correctly diagnose a cutaneous condition. As the Advanced Practice Nurse (APN) employs the
Valparaiso University College of Nursing APN Model (Figure 14) and applies critical thinking to
the environmental influences such as lack of SOC content in curriculum, he/she may transition
to the leader, teacher, consultant, or life-long learner clinician treating the at-risk population with
quality tools in technology, textbooks, and online resources. This change process is necessary
as the societal skin type demographics are rapidly transforming. Limited to one healthcare
practice, future EBP implementations would be wise to include increased numbers, additional
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departments such as primary care and other specialties, equal representation of gender and
further advanced training.

Figure 14
Valparaiso College of Nursing Advanced Practice Nurse Model

Note: Reprinted from https://www.valpo.edu/college-of-nursing-and-healthprofessions/academics/nursing/ on March 15, 2021

EBP Model
Evidence-based practice is essential for prudent, dependable, accurate healthcare. The
JH Model (Vera, 2018) (Figure 3) was helpful in dissecting relevant literature for the EBP project
leading the investigator to establish a strategy for VisualDx implementation. The systematic
analysis of literature allows the investigator to critique the evidence with an efficient, methodical
approach. What this investigator found most supportive was the JH Model’s three-step process
(PET), particularly Appendix D and its ability to guide one through the research studies
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establishing and confirming the levels and qualities of each piece of evidence. Appendix I
assists in recruiting the leader and the team as well as confirming support, but this project was
so readily accepted the investigator needed only to establish critical timelines.
Research
Further research is warranted in SOC patients. Implementation of the VisualDx
application in primary care and urgent care settings with data tracking of all skin types would
alleviate provider stress and increase positive patient outcomes. Direct implications for nursing
research include larger participant pool, longer duration of study, involve comparison groups
and additional health care systems in differing demographic populations.
Education
Further education in SOC presentation, recognition, diagnosis, and treatment is
warranted as gaps in all four areas exist. A study by Ware et al., (2020) in which 70%
dermatologists and 30% dermatology trainees (26% identifying as SOC) were supplied
electronic and in person surveys in February and March 2019 to determine how providers
describe race and ethnicity as well as how they incorporate FST into their clinical practice. Of
the 140 questionnaires, only 33% to 50% use FST to characterize race, ethnicity, or SOC. The
authors in this study surmised medical providers believe the terms race and ethnicity are
interchangeable with FST.
Race correction in algorithms and guidelines as affecting risk assessment and treatment
was examined by Park, Alston, and Washington-Brown (2021). They found databases may
include biased racial data in risk assessment and provided five examples: sickle cell disease,
body mass index, diabetes, cardiovascular disease, and pulmonary function tests. These biases
can lead to inappropriate testing, incorrectly prescribed medications, and misclassification of
disease severity and impairment. Also stated in the article: race, which is not clearly defined, is
often determined by self-identification, and providers often base racial categories on skin tone
and physical characteristics; therefore, healthcare providers must take into consideration race
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correction may not be valid in some patient evaluation and should make accommodations
appropriately.
All four providers in this project documented FST and were provided a FST reference for
accuracy. Skin type IV had the smallest group of patients (2) with congruence in both, yet two
providers never biopsied skin type IV at all, possibly due to the demographic population that
seeks dermatological treatment as referenced earlier in this paper. Type V was the largest
population (14) with equal population congruence (7), and type VI (12) was only achieved in two
cases, again highlighting the overall risk of darker skin tone and disease management.
Conclusion
Unfortunately, this study did not reveal increased diagnostic congruence with utilization
of the VisualDx platform despite provider endorsement; and although helpful, nothing compares
to education and training when attempting to accurately diagnose and establish treatment plans.
The possibility exists that VisualDx is less helpful in darker skin tones due to number of
available pictures or descriptors, but the collection continues to grow parallel to or at a minimum
positive trajectory to SOC awareness. VisualDx can be a valuable resource for differential
building and will most likely be utilized across the healthcare spectrum.
During this project, a second-year medical student from Zimbabwe named Malone
Mukwende was studying at St. George’s University in London and could not find teaching
images for darker skin tones. This educational deficiency prompted him to begin writing his own
book Mind the gap: A handbook of clinical signs in black and brown skin (yet to be published)
that will include images and corrected medical terminology for SOC in search of inclusion and
patient safety. According to an article in The Washington Post (Page, 2020), the team of three
co-authors will address childhood diseases, skin cancer, inflammatory disorders and even
Covid-19. The biggest hurdle has been allocation of images, which further aligns with previous
mentioned SOC underrepresentation. Also mentioned in the article, incoming assistant
professor at the University of Washington Patricia Louie reiterated what was previously stated
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and cited in this paper (Louie and Wilkes, 2018), noting medical textbooks overrepresented light
skin tones with only a 5% representation of darker skin tones. Her research also discovered the
majority of South Africa’s medical textbooks are equal to those in the U.S. according to image
distribution despite the predominantly black population, highlighting continued structural racism
(Page, 2020).
Change is critical to appropriate healthcare in a diverse population. VisualDx is a mobile
resource, and along with changes in medical textbook imagery as well as content, healthcare
providers should have the tools to accurately diagnose and treat patients off all skin types.

Dermatology in Skin of Color

55
REFERENCES

Adelekun, A., Onyekaba, G., & Lipoff, J. B. (2020). Skin color in dermatology textbooks: An
updated evaluation and analysis. Journal of the American Academy of Dermatology
https://doi-org.ezproxy.valpo.edu/10.1016/j.jaad.2020.04.084

Agbai, O. N., Buster, K., Sanchez, M., Hernandez, C., Kundu, R. V., Chiu, M., Roberts, W. E.,
Draelos, Z. D., Bhushan, R., Taylor, S. C., & Lim, H. W. (2014). Skin cancer and
photoprotection in people of color: A review and recommendations for physicians and
the public. Journal of the American Academy of Dermatology, 70(4), 748–762.
https://doi-org.ezproxy.valpo.edu/10.1016/j.jaad.2013.11.038

Anderson, A. M., Matsumoto, M., Saul, M. I., Secrest, A. M., & Ferris, L. K. (2018). Accuracy of
skin cancer diagnosis by physician assistants compared with dermatologists in a large
health care system. JAMA Dermatology, 154(5), 569–573.
https://doi-org.ezproxy.valpo.edu/10.1001/jamadermatol.2018.0212

Bobonich, M., & Nolen, M. (2018). Competencies for dermatology nurse practitioners. Journal of
the American Association of Nurse Practitioners, 30(11), 606–613.
https://doi-org.ezproxy.valpo.edu/10.1097/JXX.0000000000000137

Bureau, U. (2020, February 13). U.S. Census Bureau Releases National Population Projections
Reports. Retrieved July 25, 2020, from
https://www.census.gov/newsroom/press-releases/2020/population-projections.html

Dermatology in Skin of Color

56

Burke, M., & Littenberg, B. (2019). Effect of a clinical evidence technology on patient skin
disease outcomes in primary care: a cluster-randomized controlled trial. Journal of the
Medical Library Association: JMLA, 107(2), 151–162.
https://doi.org/10.5195/jmla.2019.581

Buster, K.J., Stevens, E.I., & Elmets, C.A. (2012). Dermatologic health disparities. Dermatologic
Clinics, 30(1), 53–59.

Carter, C., Farrell, A., & Mason, J. (2012). VisualDx. The Journal of the Canadian Health
Libraries Association = Journal De l'Association Des Bibliothèques De La Santé Du
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